GlassScriptPhysician profile
Carl A Diraimondo
NPI 1609967637
$23,774.47
in general payments reported to CMS, 2019-2025
5 companies · $2,993 in 2025
The $2,993 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,617 · 2020: $1,269 · 2021: $3,188 · 2022: $410 · 2023: $2,310 · 2024: $4,986 · 2025: $2,993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,558 · Food and Beverage: $2,270 · Education: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,558.29 |
| Food and Beverage | $2,269.70 |
| Education | $461.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $16,358.95 | 2019-2025 | |
| Great Lakes Orthopedics | $2,860.11 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $2,720.56 | 2021-2025 | Rosa, Oxford, Oxford Partial Knee |
| True North Surgical INC | $1,684.61 | 2023-2025 | |
| Depuy Synthes Sales INC. | $150.24 | 2019-2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Diraimondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.